[Bacteriological studies of butirosin sulfate, a new aminoglycoside antibiotic (author's transl)].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002076:Butirosin Sulfate / Q000494:pharmacology* / Q000627:therapeutic use; D003013:Clostridium / Q000187:drug effects; D003353:Corynebacterium diphtheriae / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D004927:Escherichia coli Infections / Q000188:drug therapy; D005839:Gentamicins / Q000494:pharmacology / Q000627:therapeutic use; D007612:Kanamycin / Q000494:pharmacology / Q000627:therapeutic use; D007711:Klebsiella pneumoniae / Q000187:drug effects; D008297:Male; D051379:Mice; D008826:Microbial Sensitivity Tests; D009343:Neisseria / Q000187:drug effects; D011511:Proteus / Q000187:drug effects; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D012760:Shigella / Q000187:drug effects; D013203:Staphylococcal Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D002076:Butirosin Sulfate; D007612:Kanamycin